Endocrinology
Clinical
Dapagliflozin may cut risk of HF hospitalization in patients with type 2 diabetes
What is the Food and Drug Administration–approved indication for dapagliflozin (Farxiga)?
News
COVID-19 can cause atypical thyroid inflammation
Patients with thyroid abnormalities during acute COVID-19, or who develop such symptoms, should have thyroid function checked every 6 months for a...
News
High obesity rates in Southern states magnify COVID threats
At least 29 states have green-lighted obesity for inclusion in the first phases of the COVID-19 vaccine rollout. That could overwhelm government...
News
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured...
News
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
News
Inpatient sodium imbalances linked to adverse COVID-19 outcomes
Hypernatremia during hospitalization was associated with increased COVID-19 mortality and to a greater need for ventilatory support.
News
Call to action on obesity amid COVID-19 pandemic
Hundreds of thousands of deaths worldwide from COVID-19 could have been avoided if obesity rates were lower; call for people with obesity to be...
News
Heart failure redefined with new classifications, staging
News
Thirteen percent of patients with type 2 diabetes have major ECG abnormalities
ECGs from more than 8,000 Dutch patients with type 2 diabetes, most without known cardiovascular disease, show that major abnormalities are not...
News
More from DAPA-HF: Dapagliflozin quickly reduces heart failure events